Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 1;24(6):244-246.
doi: 10.5152/alphapsychiatry.2023.231358. eCollection 2023 Nov.

Ketamine and Electroconvulsive Therapy for Treatment-Refractory Depression

Affiliations
Editorial

Ketamine and Electroconvulsive Therapy for Treatment-Refractory Depression

Xing-Bing Huang et al. Alpha Psychiatry. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests: Wei Zheng is serving as one of the Editors in Chief of this journal. We declare that Wei Zheng had no involvement in the peer review of this article and has no access to information regarding its peer review. The authors have no conflict of interest to declare.

References

    1. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27 30. (10.1038/475027a) - DOI - PMC - PubMed
    1. Lu J, Xu X, Huang Y, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2021;8(11):981 990. (10.1016/S2215-0366(21)00251-0) - DOI - PubMed
    1. Rush AJ, Warden D, Wisniewski SR, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23(8):627 647. (10.2165/00023210-200923080-00001) - DOI - PubMed
    1. Bergfeld IO, Mantione M, Figee M, Schuurman PR, Lok A, Denys D. ­Treatment-resistant depression and suicidality. J Affect Disord. 2018;235:362 367. (10.1016/j.jad.2018.04.016) - DOI - PubMed
    1. Zheng W, Li XH, Zhu XM, et al. Adjunctive ketamine and electro­convulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials. J Affect Disord. 2019;250:123 131. (10.1016/j.jad.2019.02.044) - DOI - PubMed

Publication types

LinkOut - more resources